These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 17080227)
1. Fibrinogen Darlinghurst: hypofibrinogenaemia caused by a W253G mutation in the gamma chain in a patient with both bleeding and thrombotic complications. Sheen CR; Low J; Joseph J; Kotlyar E; George PM; Brennan SO Thromb Haemost; 2006 Nov; 96(5):685-7. PubMed ID: 17080227 [No Abstract] [Full Text] [Related]
2. Paradoxical bleeding and thrombosis in a patient with afibrinogenemia and fibrinogen Mumbai mutation. Mukaddam A; Patil R; Jadli A; Chandrakala S; Ghosh K; Shetty S Am J Clin Pathol; 2015 May; 143(5):755-7. PubMed ID: 25873512 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis, clinical features and molecular assessment of the dysfibrinogenaemias. Hill M; Dolan G Haemophilia; 2008 Sep; 14(5):889-97. PubMed ID: 18564189 [TBL] [Abstract][Full Text] [Related]
4. Fibrinogen Tolaga Bay: a novel gammaAla341Val mutation causing hypofibrinogenaemia. Davis RL; Brennan SO Thromb Haemost; 2007 Nov; 98(5):1136-8. PubMed ID: 18000621 [No Abstract] [Full Text] [Related]
5. Severe bleeding and miscarriages in a hypofibrinogenemic woman heterozygous for the gamma Ala82Gly mutation. Zdziarska J; Undas A; Basa J; Iwaniec T; Skotnicki AB; de Moerloose P; Neerman-Arbez M Blood Coagul Fibrinolysis; 2009 Jul; 20(5):374-6. PubMed ID: 19300242 [TBL] [Abstract][Full Text] [Related]
6. Bbeta 14 Arg --> Cys variant dysfibrinogen and its association with thrombosis. Castaman G; Ghiotto R; Tosetto A; Rodeghiero F J Thromb Haemost; 2005 Feb; 3(2):409-10. PubMed ID: 15670063 [No Abstract] [Full Text] [Related]
7. Fibrinogen Melbourne: a novel congenital hypodysfibrinogenemia caused by γ326Cys-Phe in the fibrinogen γ chain, presenting as massive splanchnic venous thrombosis. Cheah CY; Brennan SO; Kennedy H; Januszewicz EH; Maxwell E; Burbury K Blood Coagul Fibrinolysis; 2012 Sep; 23(6):563-5. PubMed ID: 22760446 [TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with dysfibrinogenemia and a history of abortions during pregnancy. Miesbach W; Galanakis D; Scharrer I Blood Coagul Fibrinolysis; 2009 Jul; 20(5):366-70. PubMed ID: 19357502 [TBL] [Abstract][Full Text] [Related]
9. Congenital hypodysfibrinogenaemia (Fibrinogen Des Moines) due to a gamma320Asp deletion at the Ca2+ binding site. Brennan SO; Davis RL; Mosesson MW; Hernandez I; Lowen R; Alexander SJ Thromb Haemost; 2007 Aug; 98(2):467-9. PubMed ID: 17721633 [No Abstract] [Full Text] [Related]
10. Characterisation of a novel nonsense mutation in FGG (Fibrinogen Poznan) causing hypofibrinogenaemia with a mild bleeding tendency. Zawilska K; Undas A; Fish RJ; Molendowicz-Portala L; De Moerloose P; Neerman-Arbez M Thromb Haemost; 2010 Mar; 103(3):677-9. PubMed ID: 20135062 [No Abstract] [Full Text] [Related]
11. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913 [TBL] [Abstract][Full Text] [Related]
12. Recurrent VTE in a heterozygote of the fibrinogen Aα IVS4+1G>T and Aα p.Arg168Ter mutation. Berens C; Rühl H; Ivaškevičius V; Oldenburg J; Hertfelder HJ; Pötzsch B Thromb Haemost; 2016 May; 115(5):1073-5. PubMed ID: 26763372 [No Abstract] [Full Text] [Related]
13. A case of congenital afibrinogenemia: fibrinogen Hakata, a novel nonsense mutation of the fibrinogen gamma-chain gene. Iida H; Ishii E; Nakahara M; Urata M; Wakiyama M; Kurihara M; Watanabe K; Kai T; Ihara K; Kinoshita S; Hamasaki N Thromb Haemost; 2000 Jul; 84(1):49-53. PubMed ID: 10928469 [TBL] [Abstract][Full Text] [Related]
14. Fibrinogen Saint-Germain II: hypofibrinogenemia due to heterozygous gamma N345S mutation. de Raucourt E; de Mazancourt P; Maghzal GJ; Brennan SO; Mosesson MW Thromb Haemost; 2005 Nov; 94(5):965-8. PubMed ID: 16363237 [TBL] [Abstract][Full Text] [Related]
15. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications. Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352 [TBL] [Abstract][Full Text] [Related]
16. Dysfibrinogenemia (fibrinogen Wilmington) due to a novel Aalpha chain truncation causing decreased plasma expression and impaired fibrin polymerisation. Brennan SO; Mosesson MW; Lowen R; Frantz C Thromb Haemost; 2006 Jul; 96(1):88-9. PubMed ID: 16807657 [No Abstract] [Full Text] [Related]
17. Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala-->Gly and an intron two GT-->AT splice site mutation. Wyatt J; Brennan SO; May S; George PM Thromb Haemost; 2000 Sep; 84(3):449-52. PubMed ID: 11019970 [TBL] [Abstract][Full Text] [Related]
18. Fibrinogen Columbus III: A novel c.963del frameshift mutation in the FGG gene resulting in hypofibrinogenemia with a bleeding phenotype. Abdelghani E; Dawson J; Zajo K; Hallam M; Dunn A; Kumar R Pediatr Blood Cancer; 2021 Mar; 68(3):e28713. PubMed ID: 33058516 [No Abstract] [Full Text] [Related]
19. Congenital hypofibrinogenemia associated with novel heterozygous fibrinogen Bbeta and gamma chain mutations. Castaman G; Giacomelli SH; Duga S; Rodeghiero F Haemophilia; 2008 May; 14(3):630-3. PubMed ID: 18393984 [No Abstract] [Full Text] [Related]
20. Congenital fibrinogen disorders with repeated thrombosis. Zhang X; Zhang C; Wang B; Chen N; Sun G; Guo X J Thromb Thrombolysis; 2020 Feb; 49(2):312-315. PubMed ID: 31542854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]